AMLX
Amylyx Pharmaceuticals Inc
NASDAQ: AMLX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$14.73
-3.09% today
Updated 2026-05-08
Market cap
$1.69B
P/E ratio
—
P/S ratio
0.66x
EPS (TTM)
$-1.48
Dividend yield
—
52W range
$4 – $19
Volume
1.1M
Amylyx Pharmaceuticals Inc (AMLX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |